Description:

ODM derived from http://clinicaltrials.gov/show/NCT00684619

Link:
http://clinicaltrials.gov/show/NCT00684619
Keywords:
  1. 12/9/13 12/9/13 - Martin Dugas
Uploaded on:

December 9, 2013

DOI:
To request one please log in.
License :
Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00684619 T-ALL, T-NHL (Lymphoblastic)

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age at least 18 Years
T-ALL, T-NHL
cytological treatment failure / relapse
molecular treatment failure / relapse
no promising therapy alternatives with approved medication available
no CNS-manifestation, requiring intrathecal therapy or CNS-radiation
no convulsive disease or neurotoxicity > grade III in patients history
written informed consent
no cytostatic therapy in the last 10 days
no pregnancy or breastfeeding
Contraception, Birth control
recovery of toxicities of previous chemotherapy - except leukemia-related changes like bone marrow suppression or pathological transaminases in liver manifestation
Exclusion Criteria
Severe psychiatric illness
uncontrolled or severe cardiac disease or infection
active secondary neoplasms - except skin cancer (no melanoma)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial